Julio Delgado Selected Research

Julio Delgado Research Topics

Disease

42	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 11/2003
28	Neoplasms (Cancer) 02/2024 - 03/2004
8	Disease Progression 01/2021 - 09/2002
7	Multiple Myeloma 03/2024 - 02/2006
7	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 07/2010
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 01/2021
6	Asthma (Bronchial Asthma) 10/2023 - 11/2009
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2024 - 02/2002
5	Infections 10/2023 - 09/2006
5	Neutropenia 01/2023 - 01/2012
5	Diarrhea 08/2021 - 07/2014
4	Anemia 01/2023 - 12/2018
4	Fever (Fevers) 08/2021 - 07/2014
4	Nausea 07/2021 - 07/2014
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2012 - 11/2008
3	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2017
3	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2018
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 01/2017
3	Cough 08/2021 - 07/2014
3	Hairy Cell Leukemia 01/2021 - 03/2004
3	Leukemia 11/2019 - 03/2004
3	Trisomy (Trisomies) 01/2019 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 01/2002
2	Lymphoma (Lymphomas) 01/2022 - 07/2010
2	Lymphadenopathy 01/2022 - 01/2017
2	Pain (Aches) 08/2021 - 07/2021
2	Headache (Headaches) 08/2021 - 01/2021
2	Arthralgia (Joint Pain) 08/2021 - 07/2021
2	Fatigue 08/2021 - 07/2014
2	Hypersensitivity (Allergy) 01/2021 - 03/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2019 - 07/2014
2	Hemophilia A (Haemophilia) 04/2003 - 09/2002
1	Bacterial Infections (Bacterial Infection) 10/2023
1	Cross Infection (Nosocomial Infection) 10/2023
1	Inflammation (Inflammations) 10/2023
1	Philadelphia Chromosome 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023
1	Sepsis (Septicemia) 01/2023

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 05/2024 - 03/2019
8	fludarabineIBA 01/2021 - 01/2006
8	Rituximab (Mabthera)FDA Link 01/2020 - 09/2009
6	ibrutinibIBA 12/2021 - 07/2014
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2017
5	AntigensIBA 02/2024 - 01/2019
5	AllergensIBA 10/2023 - 08/2013
5	Bendamustine Hydrochloride FDA Link 01/2023 - 05/2016
5	Monoclonal AntibodiesIBA 12/2021 - 02/2002
4	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 09/2006
4	idelalisibIBA 02/2022 - 01/2017
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2016
3	Phosphotransferases (Kinase)IBA 01/2023 - 10/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 09/2009
3	ofatumumab FDA Link 01/2020 - 07/2014
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2012 - 01/2009
3	Melphalan (Alkeran)FDA LinkGeneric 07/2010 - 02/2006
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 03/2024 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 01/2012
2	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2019
2	Hexachlorobenzene (HCB)IBA 01/2023 - 01/2022
2	CytokinesIBA 01/2023 - 01/2020
2	Proteasome InhibitorsIBA 01/2023 - 01/2021
2	obinutuzumabIBA 01/2023 - 01/2021
2	CD19 AntigensIBA 01/2022 - 12/2021
2	immunotoxin HA22IBA 01/2021 - 01/2018
2	duvelisibIBA 01/2020 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
2	RNA Splicing FactorsIBA 10/2019 - 12/2011
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2019 - 01/2019
2	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2013 - 09/2009
2	purineIBA 12/2012 - 12/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2009 - 01/2009
2	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 01/2009
2	Alemtuzumab (Campath)FDA Link 11/2008 - 02/2006
1	B-Cell Maturation AntigenIBA 05/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2023
1	Long Noncoding RNAIBA 10/2023
1	Immunoglobulin E (IgE)IBA 10/2023
1	ThrombomodulinIBA 01/2023
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	asciminibIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 01/2023
1	von Willebrand FactorIBA 01/2023
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2023
1	EnzymesIBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023

Therapy/Procedure

34	Therapeutics 04/2024 - 02/2002
8	Cell Transplantation 04/2024 - 01/2006
7	Immunotherapy 01/2023 - 09/2002
5	Stem Cell Transplantation 04/2024 - 01/2009
3	Transplantation 01/2012 - 02/2006
3	Drug Therapy (Chemotherapy) 07/2010 - 09/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
2	Homologous Transplantation 11/2010 - 02/2006
2	Osteotomy 07/2006 - 09/2005
1	Catheters 10/2023
1	Precision Medicine 10/2023
1	Biological Therapy 10/2023